Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 112,550

Sort by:

Methionine Aminopeptidase 2 (Metap2) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Methionine Aminopeptidase 2 (Metap2) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Methionine Aminopeptidase 2 (Metap2) Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

mGlu 2/3 Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “mGlu 2/3 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the mGlu 2/3 Agonist. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

mGlu 2/3/5 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “mGlu 2/3/5 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the mGlu 2/3/5 Antagonist. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

mGlu5 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “mGlu5 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the mGlu5 Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Mitochondrial Electron Transport Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Mitochondrial Electron Transport Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor-Pipeline Intelligence, 2019”, report ... by identifying potential partners with progressing projects for Mitogen Activated Protein Kinase Kinase (MEK or MAP2K) Inhibitor to enhance and ...

December 2018 60 pages

Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor-Pipeline Intelligence, 2019”, ... by identifying potential partners with progressing projects for Mitogen Activated Protein Kinase Kinase 2 (MEK-2 or MAP2K2) Inhibitor to ...

December 2018 60 pages

Monoamine Oxidase Inhibitor (MAOIs) -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Monoamine Oxidase Inhibitor (MAOIs)-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Monoamine Oxidase Inhibitor (MAOIs). Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Monoamine Oxidase B (MAO-B) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Monoamine Oxidase B (MAO-B) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Monoamine Oxidase B (MAO-B) Inhibitor R&D Please note: Certain sections in the ...

December 2018 60 pages

mTORC-1 Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “mTORC-1 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the mTORC-1 Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

mTORC-2 Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “mTORC-2 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the mTORC-2 Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Mu Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Mu Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the Mu Antagonist. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

Murine Double Minute 2 (MDM2) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... the clients within 1-2 Business Days. CmaxInsight’s, “Murine Double Minute 2 (MDM2) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Murine Double Minute 2 (MDM2) Inhibitor to enhance and expand business potential ...

December 2018 60 pages

Muscarinic Acetylcholine Receptor (mAChR) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Muscarinic Acetylcholine Receptor (mAChR) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Muscarinic Acetylcholine Receptor (mAChR) Antagonist R&D Please note: Certain sections in ...

December 2018 60 pages

Muscarinic Acetylcholine Receptor M2 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Muscarinic Acetylcholine Receptor M2 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Muscarinic Acetylcholine Receptor M2 Antagonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Muscarinic Acetylcholine Receptor M3 Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Muscarinic Acetylcholine Receptor M3 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Muscarinic Acetylcholine Receptor M3 Antagonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Muscarinic Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Muscarinic Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Muscarinic Agonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Muscarinic M1 Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Muscarinic M1 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Muscarinic M1 Agonist. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

Myostatin Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Myostatin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Myostatin Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Neurokinin (NK) Receptor Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Neurokinin (NK) Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Neurokinin (NK) Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Neurokinin 1 (NK1) Receptor Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Neurokinin 1 (NK1) Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Neurokinin 1 (NK1) Receptor Agonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Neuronal Nitric Oxide Synthase (nNOS or Type I NOS) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... to the clients within 1-2 Business Days. CmaxInsight’s, “Neuronal Nitric Oxide Synthase (nNOS or Type I NOS) Inhibitor-Pipeline Intelligence, 2019”, report ... by identifying potential partners with progressing projects for Neuronal Nitric Oxide Synthase (nNOS or Type I NOS) Inhibitor to enhance and ...

December 2018 60 pages

Neutrophil Elastase Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Neutrophil Elastase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Neutrophil Elastase Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

NMDA Receptor Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “NMDA Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the NMDA Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Non Selective COX Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Business Days. CmaxInsight’s, “Non Selective COX Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Non Selective COX Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Non-Receptor Tyrosine Kinase Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Non-Receptor Tyrosine Kinase Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Non-Structural Protein 5 Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Non-Structural Protein 5 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Non-Structural Protein 5 Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor-Pipeline Intelligence, 2019”, report ... potential partners with progressing projects for Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor to enhance and ...

December 2018 60 pages

Notch Signaling Pathway Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Notch Signaling Pathway Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Notch Signaling Pathway Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Nrf2 Pathway Activators -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Nrf2 Pathway Activators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Nrf2 Pathway Activators. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s-Pipeline Intelligence, 2019”, report provides comprehensive ... identifying potential partners with progressing projects for Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s to enhance and expand ...

December 2018 60 pages

Opioid Receptor Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Opioid Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Opioid Receptor Agonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Orexin Receptor (Hypocretin Receptor) Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Orexin Receptor (Hypocretin Receptor) Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Orexin Receptor (Hypocretin Receptor) Antagonist R&D Please note: Certain sections in the ...

December 2018 60 pages

Ornithine Decarboxylase (ODC) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Ornithine Decarboxylase (ODC) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

OX-40 Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “OX-40 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the OX-40 Agonist. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

P2X7 Receptor Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “P2X7 Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the P2X7 Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

P2Y12 Platelet ADP Receptor Antagonist -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “P2Y12 Platelet ADP Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence P2Y12 Platelet ADP Receptor Antagonist R&D Please note: Certain sections in the ...

December 2018 60 pages

p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitor-Pipeline Intelligence, 2019”, report provides ... potential partners with progressing projects for p70S6 Kinase (p70S6K or 70-kDa Ribosomal Protein S6 Kinase) Inhibitor to enhance and expand ...

December 2018 60 pages

Parathyroid Hormone Receptor Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... Days. CmaxInsight’s, “Parathyroid Hormone Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Parathyroid Hormone Receptor Agonist. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

PDE Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “PDE Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the PDE Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

PDE 1 Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “PDE 1 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the PDE 1 Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

PDE 10 inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “PDE 10 inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the PDE 10 inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

Penicillin-Binding Proteins (PBPs) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... coverage of MoA enables the client to understand the landscape of the Penicillin-Binding Proteins (PBPs) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

December 2018 60 pages

Peroxisome Proliferator-Activated Receptor (PPAR) Agonist -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Peroxisome Proliferator-Activated Receptor (PPAR) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Peroxisome Proliferator-Activated Receptor (PPAR) Agonist R&D Please note: Certain sections in ...

December 2018 60 pages

Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... potential partners with progressing projects for Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor to enhance and expand business ...

December 2018 60 pages

Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... clients within 1-2 Business Days. CmaxInsight’s, “Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... potential partners with progressing projects for Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitor to enhance and expand business ...

December 2018 60 pages

PI3K Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “PI3K Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the PI3K Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

PI3K/mTOR Pathway Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “PI3K/mTOR Pathway Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the PI3K/mTOR Pathway Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Pim Kinase Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... 1-2 Business Days. CmaxInsight’s, “Pim Kinase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Pim Kinase Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

December 2018 60 pages

Plasmin Inhibitor -Pipeline Intelligence, 2019

US$ 1,000.00

... within 1-2 Business Days. CmaxInsight’s, “Plasmin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Plasmin Inhibitor. Pipeline Covered: This section mentions all the promising ...

December 2018 60 pages

Filters

Clear all